Health News Archive - June 16, 2012
A new approach to drug design, pioneered by a group of researchers at the University of California, San Francisco (UCSF) and Mt. Sinai, New York, promises to help identify future drugs to fight cancer and other diseases that will be more effective and have fewer side effects.
In other studies, outcomes of specific surgeries has been shown to improve when performed at high-volume centralized centers.
University of Texas Medical Branch at Galveston researchers have found a surprising connection between a key DNA-repair process and a cellular signaling network linked to aging, heart disease, cancer and other chronic conditions.
AMSTERDAM, June 16, 2012 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH) joined the European Hematology Association (EHA) and the European Cancer Patient Coalition (ECPC)
Abstract # 1970: The Bruton's Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) is Highly Active and Tolerable in Relapsed or Refractory and Treatment Naive Chronic Lymphocytic Leukemia Patients, Updated Results of a Phase Ib/II Study.
Approximately one out of every five teenagers, including some as young as fourteen years old, are sending or receiving sexually explicit photos, claims a new study published online earlier this month in the journal Archives of Sexual Behavior.
The 100 Releases a Prostate Cancer Statement in Recognition of Men's Health Week and Father's Day to Educate and Empower Men at Highest Risk of Developing Prostate Cancer